These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23578372)

  • 1. Treatment response of HPV-positive and HPV-negative head and neck squamous cell carcinoma cell lines.
    Nagel R; Martens-de Kemp SR; Buijze M; Jacobs G; Braakhuis BJ; Brakenhoff RH
    Oral Oncol; 2013 Jun; 49(6):560-6. PubMed ID: 23578372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.
    Spanos WC; Nowicki P; Lee DW; Hoover A; Hostager B; Gupta A; Anderson ME; Lee JH
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1137-46. PubMed ID: 19917928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status.
    Vlashi E; Chen AM; Boyrie S; Yu G; Nguyen A; Brower PA; Hess CB; Pajonk F
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1198-206. PubMed ID: 27026319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines.
    Busch CJ; Becker B; Kriegs M; Gatzemeier F; Krüger K; Möckelmann N; Fritz G; Petersen C; Knecht R; Rothkamm K; Rieckmann T
    Oncotarget; 2016 Jun; 7(24):35832-35842. PubMed ID: 27127883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of radiation on cell proliferation and tumor hypoxia in HPV-positive head and neck cancer in vivo models.
    Sørensen BS; Busk M; Horsman MR; Alsner J; Overgaard J; Kyle AH; Minchinton AI
    Anticancer Res; 2014 Nov; 34(11):6297-304. PubMed ID: 25368228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
    Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
    Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of human papillomavirus in head and neck cancer.
    Lajer CB; von Buchwald C
    APMIS; 2010 Jun; 118(6-7):510-9. PubMed ID: 20553531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma.
    Geiger JL; Lazim AF; Walsh FJ; Foote RL; Moore EJ; Okuno SH; Olsen KD; Kasperbauer JL; Price DL; Garces YI; Ma DJ; Neben-Wittich MA; Molina JR; Garcia JJ; Price KA
    Oral Oncol; 2014 Apr; 50(4):311-8. PubMed ID: 24467937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment outcomes in veterans with HPV-positive head and neck cancer.
    Feinstein AJ; Shay SG; Chang E; Lewis MS; Wang MB
    Am J Otolaryngol; 2017; 38(2):188-192. PubMed ID: 28342482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of human papillomavirus and other risk factors in Lithuanian patients with head and neck cancer.
    Gudleviciene Z; Smailyte G; Mickonas A; Pikelis A
    Oncology; 2009; 76(3):205-8. PubMed ID: 19209011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome.
    Lassen P
    Radiother Oncol; 2010 Jun; 95(3):371-80. PubMed ID: 20493569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human papillomavirus genome detection by in situ hybridization in fine-needle aspirates of metastatic lesions from head and neck squamous cell carcinomas.
    Umudum H; Rezanko T; Dag F; Dogruluk T
    Cancer; 2005 Jun; 105(3):171-7. PubMed ID: 15822131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of human papillomavirus-related squamous cell carcinoma cytologically and by in situ hybridization in fine-needle aspiration biopsies of cervical metastasis: a tool for identifying the site of an occult head and neck primary.
    Zhang MQ; El-Mofty SK; Dávila RM
    Cancer; 2008 Apr; 114(2):118-23. PubMed ID: 18300234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.
    Gillison ML; D'Souza G; Westra W; Sugar E; Xiao W; Begum S; Viscidi R
    J Natl Cancer Inst; 2008 Mar; 100(6):407-20. PubMed ID: 18334711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
    Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
    BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncolytic activity of reovirus in HPV positive and negative head and neck squamous cell carcinoma.
    Cooper T; Biron VL; Fast D; Tam R; Carey T; Shmulevitz M; Seikaly H
    J Otolaryngol Head Neck Surg; 2015 Feb; 44(1):8. PubMed ID: 25890191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population-based evidence of increased survival in human papillomavirus-related head and neck cancer.
    Nygård M; Aagnes B; Bray F; Møller B; Mork J
    Eur J Cancer; 2012 Jun; 48(9):1341-6. PubMed ID: 22516210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase 2 study of bevacizumab with cisplatin plus intensity-modulated radiation therapy for stage III/IVB head and neck squamous cell cancer.
    Fury MG; Lee NY; Sherman E; Lisa D; Kelly K; Lipson B; Carlson D; Stambuk H; Haque S; Shen R; Kraus D; Shah J; Pfister DG
    Cancer; 2012 Oct; 118(20):5008-14. PubMed ID: 22415650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus-related head and neck tumors: clinical and research implication.
    Psyrri A; Gouveris P; Vermorken JB
    Curr Opin Oncol; 2009 May; 21(3):201-5. PubMed ID: 19370803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of human papillomavirus in the survival of head and neck cancer patients: an overview of the evidence.
    Schlecht NF
    Oncol Rep; 2005 Nov; 14(5):1239-47. PubMed ID: 16211291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.